Aquestive therapeutics (AQST) SVP sells $70,000 in stock
NeutralFinancial Markets

In a recent development, a senior vice president at Aquestive Therapeutics sold $70,000 worth of stock. This transaction is noteworthy as it reflects the company's ongoing financial activities and can influence investor perceptions. While such sales are common in the corporate world, they often raise questions about the insider's confidence in the company's future performance.
— Curated by the World Pulse Now AI Editorial System